(Q43050911)

13 November 2017

Tumour cell products inhibit both functional and immunoreactive interleukin 2 production by human blood lymphocytes (English)

1 reference

13 November 2017

Nelson M

1

1 reference

13 November 2017

Bremner JA

series ordinal

2

1 reference

13 November 2017

Nelson DS

series ordinal

3

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

British Journal of Cancer

13 November 2017

1 reference

13 November 2017

60

1 reference

13 November 2017

2

1 reference

13 November 2017

161-163

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1989.243

13 November 2017

0 references

cites work

Inhibition of cytokine production by a tumor cell product.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

Natural killer cells: their roles in defenses against disease

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

Inhibition of interleukin 2 production by factors released from tumor cells.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

Cancer and subversion of host defences.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

Evasion of host defences by tumours

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

Contra-IL 2; a suppressor lymphokine that inhibits IL 2 activity

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

T cell growth factor: parameters of production and a quantitative microassay for activity

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247037

Characterization of an inhibitor of cell division released in tumour cell cultures

16 August 2018

1 reference

12 December 2020

Inhibition of cell-mediated immunity by tumour cell products: depression of interleukin-2 production and responses to interleukin-2 by mouse spleen cells

1 reference

12 December 2020

Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.243

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

2788451

1 reference